Literature DB >> 15023995

Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.

Saranette Cheng1, Hassan Afif, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Xinfang Li, Katherine Farrajota, Martin Lavigne, Hassan Fahmi.   

Abstract

Membrane-associated prostaglandin (PG) E(2) synthase-1 (mPGES-1) catalyzes the conversion of PGH(2) to PGE(2), which contributes to many biological processes. Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor and plays an important role in growth, differentiation, and inflammation in different tissues. Here, we examined the effect of PPARgamma ligands on interleukin-1beta (IL-1beta)-induced mPGES-1 expression in human synovial fibroblasts. PPARgamma ligands 15-deoxy-Delta(12,14) prostaglandin J(2) (15d-PGJ(2)) and the thiazolidinedione troglitazone (TRO), but not PPARalpha ligand Wy14643, dose-dependently suppressed IL-1beta-induced PGE(2) production, as well as mPGES-1 protein and mRNA expression. 15d-PGJ(2) and TRO suppressed IL-1beta-induced activation of the mPGES-1 promoter. Overexpression of wild-type PPARgamma further enhanced, whereas overexpression of a dominant negative PPARgamma alleviated, the suppressive effect of both PPARgamma ligands. Furthermore, pretreatment with an antagonist of PPARgamma, GW9662, relieves the suppressive effect of PPARgamma ligands on mPGES-1 protein expression, suggesting that the inhibition of mPGES-1 expression is mediated by PPARgamma. We demonstrated that PPARgamma ligands suppressed Egr-1-mediated induction of the activities of the mPGES-1 promoter and of a synthetic reporter construct containing three tandem repeats of an Egr-1 binding site. The suppressive effect of PPARgamma ligands was enhanced in the presence of a PPARgamma expression plasmid. Electrophoretic mobility shift and supershift assays for Egr-1 binding sites in the mPGES-1 promoter showed that both 15d-PGJ(2) and TRO suppressed IL-1beta-induced DNA-binding activity of Egr-1. These data define mPGES-1 and Egr-1 as novel targets of PPARgamma and suggest that inhibition of mPGES-1 gene transcription may be one of the mechanisms by which PPARgamma regulates inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023995     DOI: 10.1074/jbc.M402828200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee.

Authors:  S Cheng; H Afif; J Martel-Pelletier; M Benderdour; J-P Pelletier; G Hilal; P Haraoui; J-P Raynauld; D Choquette; H Fahmi
Journal:  Ann Rheum Dis       Date:  2006-10       Impact factor: 19.103

2.  Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.

Authors:  William E Ackerman; Xiaolan L Zhang; Brad H Rovin; Douglas A Kniss
Journal:  Biol Reprod       Date:  2005-04-20       Impact factor: 4.285

Review 3.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

Review 4.  Licofelone: the answer to unmet needs in osteoarthritis therapy?

Authors:  Shrinivas K Kulkarni; Vijay P Singh
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

5.  Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.

Authors:  Tove Båge; Johan Lindberg; Joakim Lundeberg; Thomas Modéer; Tülay Yucel-Lindberg
Journal:  BMC Genomics       Date:  2010-04-15       Impact factor: 3.969

6.  Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes.

Authors:  Shu-Huang Chen; Hassan Fahmi; Qin Shi; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-02-09       Impact factor: 5.156

7.  PPARγ agonists target aromatase via both PGE2 and BRCA1.

Authors:  Ofer Margalit; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Prev Res (Phila)       Date:  2012-10

Review 8.  Heme oxygenase and carbon monoxide initiate homeostatic signaling.

Authors:  Martin Bilban; Arvand Haschemi; Barbara Wegiel; Beek Y Chin; Oswald Wagner; Leo E Otterbein
Journal:  J Mol Med (Berl)       Date:  2007-11-22       Impact factor: 4.599

Review 9.  New thoughts on the pathophysiology of osteoarthritis: one more step toward new therapeutic targets.

Authors:  Johanne Martel-Pelletier; Daniel Lajeunesse; Hassan Fahmi; Ginette Tardif; Jean-Pierre Pelletier
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

Review 10.  Cartilage homeostasis in health and rheumatic diseases.

Authors:  Mary B Goldring; Kenneth B Marcu
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.